Revolutionizing Futures: Groundbreaking Treatments for Autism and Dementia

Revolutionizing Futures: Groundbreaking Treatments for Autism and Dementia

In this episode, Ryan interviews Liz Ferrantinos, the co-founder and CEO of Meizon Innovation, and Wah Chin, the Inventor and CSO of the company. They delve into groundbreaking treatments for autism and dementia, discussing the intricacies of their research, which involves understanding hormone effects in the brain and the role of environmental factors.   Liz explains their two key treatments: DL33 for dementia, particularly Niemann-Pick Type C, a rare childhood dementia many are unaware of, and MO8 for autism spectrum disorder. Wah Chin shares insights from their 20 years of research on autism, emphasizing the alarming increase in autism prevalence since the 1980s and the potential link to environmental factors like plastic exposure.   They also discuss the significant progress they've made with the FDA regarding their treatments, the unique challenges they face, and their commitment to helping those affected by these conditions. The episode sheds light on the intersection of medical innovation and personal passion, particularly as Liz shares her emotional connection to dementia disease following her mother's experience.   Tune in to explore the science behind these revolutionary treatments and learn how you can support their mission in reshaping futures for those affected by autism and dementia.

Ryan x Julian Fayad, Founder & CEO of LoanOptions.ai

Featuring Julian Fayad, Founder & CEO of LoanOptions.ai. The discussion covers the professional journey of the founder, the setbacks and come backs & how founders can implement some of these lessons in their own businesses.